Aclarion Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Aclarion Inc.
- Former names
- Nocimed, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Broomfield
- Headquarters state / province
- Colorado
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ACON
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001635077
- EIN
- 47-3324725
Board of directors
-
Amanda Mae Sequira · DirectorSince 2026
-
Brent Ness · Director · Chief Executive OfficerSince 2025
-
David K. Neal · DirectorSince 2026
-
Jeffrey John Thramann · Director · Executive ChairmanSince 2023
-
Ryan Bond · DirectorSince 2026
-
Scott Breidbart · DirectorSince 2026
-
Stephen Deitsch · DirectorSince 2026
-
William Wesemann · DirectorSince 2026
Chief executives
Brent Ness
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
60.2%
-
67.5%
-
67.9%
-
68.0%
-
68.4%
-
68.4%
Board connections
2 of this board's directors also sit on 1 other board.
- via Jeffrey John Thramann and Stephen Deitsch
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $176,647
- 11 purchases by 7 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Amanda Mae Sequira Director | Open-market purchase | +5,857 | $2.73 | $15,990 |
| Aug 14, 2026 | Gould Gregory A Officer (CFO) | Open-market purchase | +10,000 | $2.45 | $24,500 |
| Aug 13, 2026 | Brent Ness Director, Officer (Chief Executive Officer) | Open-market purchase | +5,234 | $2.31 | $12,091 |
| Aug 13, 2026 | David K. Neal Director | Open-market purchase | +7,500 | $2.40 | $18,000 |
| Aug 13, 2026 | William Wesemann Director | Open-market purchase | +2,150 | $2.34 | $5,031 |
| Aug 13, 2026 | Ryan Bond Director | Open-market purchase | +21,122 | $2.37 | $50,059 |
| Jun 11, 2026 | Bond Ryan Officer (Chief Strategy Officer) | Grant or award | +55,000 | — | — |
| Jun 11, 2026 | Amanda Mae Sequira Director | Grant or award | +20,000 | — | — |
| Jun 11, 2026 | Gould Gregory A Officer (Chief Financial Officer) | Grant or award | +50,000 | — | — |
| Jun 11, 2026 | Scott Breidbart Director | Grant or award | +20,000 | — | — |
| Jun 11, 2026 | Brent Ness Director, Officer (Chief Executive Officer) | Grant or award | +100,000 | — | — |
| Jun 11, 2026 | William Wesemann Director | Grant or award | +20,000 | — | — |
| Jun 11, 2026 | David K. Neal Director | Grant or award | +20,000 | — | — |
| Jun 11, 2026 | Jeffrey John Thramann Director, Officer (Executive Chairman) | Grant or award | +100,000 | — | — |
| Jun 11, 2026 | Stephen Deitsch Director | Grant or award | +20,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.